A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS
Not Applicable
Completed
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- American National Red Cross
- Registration Number
- NCT00001999
- Locations
- 🇺🇸
Georgetown Univ Med Ctr, Washington, District of Columbia, United States
© Copyright 2024. All Rights Reserved by MedPath